A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC)
Condition(s):Primary Biliary CirrhosisLast Updated:February 20, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Primary Biliary CirrhosisLast Updated:February 20, 2020Unknown status
Condition(s):Short Bowel SyndromeLast Updated:February 24, 2017Completed
Condition(s):Type II DiabetesLast Updated:November 1, 2017Completed
Condition(s):Cirrhosis; Hepatocellular Carcinoma; Liver Transplant; MicrobiotaLast Updated:November 5, 2019Unknown status
Condition(s):Hepatitis B, ChronicLast Updated:March 5, 2018Completed
Condition(s):Chronic Hepatitis D InfectionLast Updated:March 12, 2024Recruiting
Condition(s):Overweight and ObesityLast Updated:October 13, 2023Recruiting
Condition(s):Type 2 Diabetes MellitusLast Updated:May 8, 2019Completed
Condition(s):Chronic Hepatitis D InfectionLast Updated:March 15, 2024Recruiting
Condition(s):Diabetes Mellitus, Type 2; Hydroxymethylglutaryl-CoA Reductase InhibitorsLast Updated:March 3, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.